Table 3 In vitro cytotoxicity of compounds 1–5
Compound Codes | HeLa (Cervical cancer) (IC50± S.D.) μM | PC-3 (Prostate cancer) (IC50±S.D.) μM |
|---|---|---|
1 | >50 | >50 |
2 | 16.83±0.96 | 24.87±0.72 |
3 | >50 | >50 |
4 | 37.20 ± 0.88 | >50 |
5 | >50 | >50 |
Doxorubicin | 3.10 ± 0.20 | 0.91 ± 0.12 |
Compound Codes | HeLa (Cervical cancer) (IC50± S.D.) μM | PC-3 (Prostate cancer) (IC50±S.D.) μM |
|---|---|---|
1 | >50 | >50 |
2 | 16.83±0.96 | 24.87±0.72 |
3 | >50 | >50 |
4 | 37.20 ± 0.88 | >50 |
5 | >50 | >50 |
Doxorubicin | 3.10 ± 0.20 | 0.91 ± 0.12 |